The effect of vitamin D supplementation in diabetic dialysis patients

Randomized, double blinded, case-control clinical trial on effect of vitamin D supplementation on metabolic profiles in diabetic Hemodialysis patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017040924625N4

Enrollment

Registered

2017-05-11

Start date

2017-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitamin D supplementation in hemodialysis. Preparatory care for dialysis

Interventions

Intervention 1: The intervention group will receive pearl of vitamin D, 50000 IU weekly for 12 weeks. Patients encourage to do not change their normal physical activity in this period. Intervention 2:

Treatment - Drugs

Placebo

The intervention group will receive pearl of vitamin D, 50000 IU weekly for 12 weeks. Patients encourage to do not change their normal physical activity in this period.

The intervention group will receive placebo pearl similar to vitamin D pearl for 12 weeks. Patients encourage to do not change their normal physical activity in this period.

Eligibility

Sex/Gender

All

Age

45 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Hemodialysis patients with malnutrition or hyperkalemia; Diabetes mellitus. Exclusion criteria: Overt Diabetes; Smoking; Hypothyroidism or hyperthyroidism; Any disease that need to hospitalization; Hypertension

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Insulin metabolism markers. Timepoint: At the first and end of study (3 months period). Method of measurement: Laboratory tests and mathematical calculations.	—

Secondary

Measure	Time frame
Oxidative stress. Timepoint: At the first and end of study (3 months period). Method of measurement: Laboratory tests.;Inflammatory biomarkers. Timepoint: At the first and end of study (3 months period). Method of measurement: Laboratory tests.;Lipid profiles. Timepoint: At the first and end of study (3 months period). Method of measurement: Laboratory tests.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Reza Tamadon

Semnan University of Medical Sciences

mrt_tamadon@yahoo.com+98 23 3142 2120

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026